Free Trial

Acadia Healthcare (NASDAQ:ACHC) Stock Price Down 2.9% - Here's Why

Acadia Healthcare logo with Medical background

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report)'s stock price traded down 2.9% during mid-day trading on Wednesday . The company traded as low as $43.01 and last traded at $43.07. 515,229 shares traded hands during trading, a decline of 74% from the average session volume of 2,003,954 shares. The stock had previously closed at $44.37.

Wall Street Analysts Forecast Growth

Several research firms recently commented on ACHC. StockNews.com lowered shares of Acadia Healthcare from a "hold" rating to a "sell" rating in a report on Monday, January 6th. TD Cowen cut their target price on shares of Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating on the stock in a research note on Tuesday, January 7th. Royal Bank of Canada reiterated an "outperform" rating and issued a $64.00 price target on shares of Acadia Healthcare in a report on Friday, January 10th. Barclays reduced their price objective on Acadia Healthcare from $76.00 to $43.00 and set an "overweight" rating on the stock in a research note on Friday, November 22nd. Finally, Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a "hold" rating to a "buy" rating and increased their target price for the company from $45.00 to $75.00 in a research note on Thursday, December 12th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $70.22.

Get Our Latest Stock Analysis on Acadia Healthcare

Acadia Healthcare Stock Performance

The company's fifty day simple moving average is $40.64 and its two-hundred day simple moving average is $57.57. The company has a market capitalization of $4.00 billion, a price-to-earnings ratio of 14.11, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm had revenue of $815.60 million during the quarter, compared to analyst estimates of $819.42 million. During the same period in the previous year, the company earned $0.91 earnings per share. Acadia Healthcare's quarterly revenue was up 8.7% on a year-over-year basis. Equities research analysts predict that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Institutional Trading of Acadia Healthcare

Several institutional investors have recently added to or reduced their stakes in the business. Harbor Capital Advisors Inc. raised its stake in Acadia Healthcare by 302.0% during the fourth quarter. Harbor Capital Advisors Inc. now owns 90,772 shares of the company's stock worth $3,599,000 after acquiring an additional 68,190 shares during the period. Everence Capital Management Inc. acquired a new stake in shares of Acadia Healthcare during the 4th quarter worth approximately $203,000. GAMMA Investing LLC lifted its holdings in shares of Acadia Healthcare by 259.6% in the 4th quarter. GAMMA Investing LLC now owns 2,384 shares of the company's stock worth $95,000 after purchasing an additional 1,721 shares during the last quarter. JPMorgan Chase & Co. boosted its position in Acadia Healthcare by 17.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock valued at $198,258,000 after purchasing an additional 454,044 shares during the period. Finally, Principal Financial Group Inc. grew its stake in Acadia Healthcare by 2.1% during the 3rd quarter. Principal Financial Group Inc. now owns 656,889 shares of the company's stock worth $41,653,000 after buying an additional 13,368 shares during the last quarter.

Acadia Healthcare Company Profile

(Get Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Featured Articles

Should You Invest $1,000 in Acadia Healthcare Right Now?

Before you consider Acadia Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.

While Acadia Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in February 2025
How To Invest in Crypto as A Complete BEGINNER in 2025
3 AI Bargain Stocks to BUY NOW After the DeepSeek Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines